4//SEC Filing
Gaston-Dreyfus Remi 4
Accession 0001104659-19-067939
CIK 0001508381other
Filed
Nov 26, 7:00 PM ET
Accepted
Nov 27, 10:31 AM ET
Size
7.5 KB
Accession
0001104659-19-067939
Insider Transaction Report
Form 4
Gaston-Dreyfus Remi
Director
Transactions
- Conversion
Common Stock
2019-11-25+4,997→ 1,282,634 total(indirect: Shares held through RGD Investissements and Lombard International Assurance SA) - Conversion
Exchangeable Shares
2019-11-25−4,997→ 17,476 total(indirect: Exchangeable Shares held through Lombard International Assurance SA)→ Common Stock (22,473 underlying)
Footnotes (1)
- [F1]The Exchangeable Shares of the Issuer's indirect subsidiary beneficially held by the Reporting Person are convertible into common stock of the Issuer at any time on a one-for-one basis for no consideration, and have no expiration date.
Documents
Issuer
Bionik Laboratories Corp.
CIK 0001508381
Entity typeother
Related Parties
1- filerCIK 0001716639
Filing Metadata
- Form type
- 4
- Filed
- Nov 26, 7:00 PM ET
- Accepted
- Nov 27, 10:31 AM ET
- Size
- 7.5 KB